| Health / Medical Topics |
ALK Inhibitor CH5424802
An orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity. Upon administration, ALK inhibitor CH542480 binds to and inhibits ALK kinase, ALK fusion proteins as well as the gatekeeper mutation ALKL1196M known as one of the mechanisms of acquired resistance to small-molecule kinase inhibitors. The inhibition leads to disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. ALK dysregulation and gene rearrangements are associated with a series of tumors. (NCI Thesaurus)
YOU MAY ALSO LIKE
A gene that makes a protein called anaplastic lymphoma kinase (ALK), which may be involved in cell growth. Mutated (changed) forms of…
A fluorescence in situ hybridization kit that detects the rearrangements between the ALK gene which is located at 2p23 and all known…
A substituted benzamide that acts as a dopamine receptor antagonist with antiemetic properties.
An orally- and topically-active naturally-occurring retinoic acid with antineoplastic, chemopreventive, teratogenic, and embryotoxic activities. Alitretinoin binds to and activates nuclear retinoic acid…
A species of strictly anaerobic, Gram negative, rod shaped bacteria assigned to the phylum Bacteroidetes. This bacteria is non-motile, hemolytic, hydrolyzes gelatin,…
An orally active nonpeptide renin inhibitor with antihypertensive activity. Aliskiren selectively binds to the S3 sub-pocket of renin, an enzyme in the…
